PKM and cancer: Since compound 3K has been proven to be a specific PKM2 inhibitor and shows anticancer effects in various human cancer lines, including SK-OV-3, HCT116, and Hela [18,19], this study compared the anticancer effects of compound 3h and compound 3K on the LNCaP cell line.